Free Trial

Swedish Orphan Biovitrum AB (publ) (BIOVF) News Today

Swedish Orphan Biovitrum AB (publ) logo
$31.38 0.00 (0.00%)
(As of 11/15/2024 ET)
Swedish Orphan Biovitrum AB (publ) stock logo
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Short Interest Update
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF - Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 1,038,600 shares, a growth of 33.0% from the September 30th total of 780,900 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 10,386.0 days.
Kepler Capital downgrades Swedish Orphan Biovitrum AB (0MTD) to a Hold
Swedish Orphan Biovitrum AB (publ) stock logo
Short Interest in Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Decreases By 9.6%
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF - Get Free Report) saw a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 1,107,000 shares, a decline of 9.6% from the August 15th total of 1,224,400 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 11,070.0 days.
Swedish Orphan Biovitrum AB (publ) stock logo
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Hits New 12-Month High at $31.28
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Hits New 12-Month High at $31.28
Swedish Orphan Biovitrum AB (publ) stock logo
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Reaches New 12-Month High at $30.55
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Sets New 52-Week High at $30.55
Swedish Orphan Biovitrum AB (publ) (BIOVF)
Swedish Orphan Biovitrum AB (0MTD) Receives a Buy from RBC Capital
Swedish Orphan Biovitrum AB (publ) stock logo
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Stock Price Down 1.7%
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Trading Down 1.7%
Swedish Orphan Biovitrum AB (publ) (SOBI.ST)
Swedish Orphan Biovitrum AB earnings: here's what to expect
Swedish Orphan Biovitrum AB (publ) stock logo
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Sets New 52-Week High at $27.79
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Reaches New 12-Month High at $27.79
Swedish Orphan Biovitrum AB (publ) (SWOBY)
Invitation: Sobi's Q4 and FY 2023 report
Swedish Orphan Biovitrum AB BIOVF
Sobi has completed the issuances of series C shares
Reminder: Invitation: Sobi's Q3 2023 report
Invitation: Sobi's Q3 2023 report
Sobi KOL investor event: the journey for Vonjo®
Get Swedish Orphan Biovitrum AB (publ) News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIOVF and its competitors with MarketBeat's FREE daily newsletter.

Trump’s EPIC Stock Market Rally (Ad)

Putting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to Jim, getting in now could turn $10,000 into as much as $265,000 by Inauguration Day.

Play this epic Trump rally for every dollar of profit possible.

BIOVF Media Mentions By Week

BIOVF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BIOVF
News Sentiment

0.50

0.57

Average
Medical
News Sentiment

BIOVF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BIOVF Articles
This Week

1

0

BIOVF Articles
Average Week

Get Swedish Orphan Biovitrum AB (publ) News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIOVF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (OTCMKTS:BIOVF) was last updated on 11/18/2024 by MarketBeat.com Staff
From Our Partners